![David B. Krizman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dr. David B. Krizman is Chief Scientific Officer at OncoPlex Diagnostics, Inc.
Dr. Krizman was previously employed as a Principal Investigator by National Cancer Institute and Senior Staff Fellow by National Human Genome Research Institute.
He received his doctorate degree from the University of Texas.
| Companies | Position | End |
|---|---|---|
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Corporate Officer/Principal | - |
National Human Genome Research Institute
 National Human Genome Research Institute General GovernmentGovernment Engages in genetic and genomic research | Corporate Officer/Principal | - |
OncoPlex Diagnostics, Inc.
 OncoPlex Diagnostics, Inc. Medical/Nursing ServicesHealth Services Operates a cancer diagnostics laboratory | Founder | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 4 |
|---|---|
OncoPlex Diagnostics, Inc.
OncoPlex Diagnostics, Inc. Medical/Nursing ServicesHealth Services Operates a cancer diagnostics laboratory | Health Services |
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Miscellaneous |
National Human Genome Research Institute
National Human Genome Research Institute General GovernmentGovernment Engages in genetic and genomic research | Government |
Select your edition
All financial news and data tailored to specific country editions
